Celltrion, Top Search Ranking... Stock Price -0.46%
As of 2:30 PM on the 17th, Celltrion is trading at 323,500 KRW, down 0.46% from the previous day. This represents a 12.8% decline compared to February 1st. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have a net purchase of 15,000 shares of Celltrion, while institutions have a net sale of 22,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 291,338 shares, foreigners have net purchased 13,046 shares, and institutions have net sold 313,008 shares respectively.
On February 8th, Celltrion was a market topic with the headline "Strong performance following MFDS approval of COVID-19 antibody treatment."
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.